HCPCS code J2329 — Inj ublituximab-xiiy, 1 mg. Status: Active. Effective Jul 1, 2023. Source: CMS HCPCS Level II.

J2329

Active

Inj ublituximab-xiiy, 1 mg

Injection, ublituximab-xiiy, 1mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2023
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 9149

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
73150-0150-06 Briumvi

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q3
    Inj ublituximab-xiiy, 1 mg